Global Regulation of Corporate Conduct: Effective Pursuit of a Slave-Free Supply Chain

68 Am. U. L. Rev. 1821 (2019).

By Roza Pati*

The New Social Contracts in International Supply Chains

68 Am. U. L. Rev. 1869 (2019).

By David V. Snyder*

Ships in the Night: Resolving Administrative Conflict Between FDA- and Patent-Related Legislation

68 Am. U. L. Rev. 1111 (2019).

By Carlos A. Garcia* and Jonathan Stroud**

Institutional Design for Innovation: A Radical Proposal for Addressing § 101 Patent-Eligible Subject Matter

68 Am. U. L. Rev. 1191 (2019).

By Kristen Osenga*

The Dark Data Quandary

68 Am. U. L. Rev. 761 (2019).

By Daniel J. Grimm*

The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling

68 Am. U. L. Rev. 823 (2019).

By Sean M. O'Connor* & Erika Lietzan**

An Error and an Evil: The Strange History of Implied Commerce Powers

68 Am. U. L. Rev. 927 (2019).

By David S. Schwartz*

Reform of Section 355

68 Am. U. L. Rev. 447 (2018).

By Bret Wells*

Beyond Balancing: Rethinking the Law of Embryo Disposition

68 Am. U. L. Rev. 515 (2018).

By Mary Ziegler*

Crypto Securities: On the Risks of Investments in Blockchained-Based Assets and the Dilemmas of Securities Regulation

68 Am. U. L. Rev.A 69 (2018).

By Shlomit Azgad-Tromer*